CDKN2A and neoplasm: MSC-AS1, AC087222.1, CDKN2A-AS1, AC009121.2 and CSTF3-AS1 had increased expression in HNSC cells, whereas ZNF710-AS1, GAS1RR, and EP300-AS1 had decreased expression in OSCC tumor cells (Fig. 10A–H).